Drugmaker Genfit Said to Explore Options Including a Sale

which is developing a drug for nonalcoholic steatohepatitis or NASH, is also weighing licensing agreements, partnerships or joint ventures, one of the people said, asking not to be identified as the…

View this article online at Bloomberg
Source: Bloomberg – Paris Agreement

More news